Primer: MicroPort CardioFlow (2160 HK) - Aug 2026
MicroPort CardioFlow is a leading player in China's transcatheter aortic valve implantation (TAVI) market, poised for growth driven by an aging...
90 Views
𝛼SK or SearchENTITY
MicroPort CardioFlow (2160 HK)
MicroPort CardioFlow (2160 HK)
63
Analysis
Health Care • China
MicroPort CardioFlow Medtech Corporation is a medical device company specializing in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases. Its product portfolio includes transcatheter aortic valves, left atrial appendage closure systems, and cardiac rhythm management devices like pacemakers and implantable cardioverter-defibrillators. The company was founded in 2015 and is headquartered in Shanghai, China.
morex